BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6099456)

  • 1. Inhibition of cyclic AMP-mediated intestinal hypersecretion by pituitary extracts from rats pretreated with cholera toxin.
    Lönnroth I; Lange S
    Med Biol; 1984; 62(5):290-4. PubMed ID: 6099456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new principle for resistance to cholera: desensitization to cyclic AMP-mediated diarrhea induced by cholera toxin in the mouse intestine.
    Lönnroth I; Lange S
    J Cyclic Nucleotide Res; 1981; 7(4):247-57. PubMed ID: 6278008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis toxin actions on the pituitary-derived 235-1 clone: effects of PGE1, cholera toxin, and forskolin on cyclic AMP metabolism and prolactin release.
    Cronin MJ; Myers GA; MacLeod RM; Hewlett EL
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(3):245-58. PubMed ID: 6199389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hormone-like protein from the pituitary gland inhibits intestinal hypersecretion induced by cholera toxin.
    Lönnroth I; Lange S
    Regul Pept Suppl; 1985; 4():216-8. PubMed ID: 3864196
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
    Nakaki T; Nakadate T; Yamamoto S; Kato R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cycloheximide on the response of intestinal mucosa to cholera enterotoxin.
    Kimberg DV; Field M; Gershon E; Schooley RT; Henderson A
    J Clin Invest; 1973 Jun; 52(6):1376-83. PubMed ID: 4349948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of the antisecretory factor: a protein in the central nervous system and in the gut which inhibits intestinal hypersecretion induced by cholera toxin.
    Lönnroth I; Lange S
    Biochim Biophys Acta; 1986 Aug; 883(1):138-44. PubMed ID: 3524692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against experimental cholera in the rat. A study on the formation of antibodies against cholera toxin and desensitization of adenylate cyclase after immunization with cholera toxin.
    Lange S; Lönnroth I; Nygren H
    Int Arch Allergy Appl Immunol; 1984; 75(2):143-8. PubMed ID: 6469386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on cholera-toxin-induced desensitization of adenylate cyclase in the mouse intestinal mucosa.
    Lönnroth I; Lange S; Hansson HA
    Int Arch Allergy Appl Immunol; 1984; 74(3):226-31. PubMed ID: 6373621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
    Cronin MJ; Thorner MO
    J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
    Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine.
    Holmgren J; Lange S; Lönnroth I
    Gastroenterology; 1978 Dec; 75(6):1103-8. PubMed ID: 213346
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorpromazine inhibits cholera toxin-induced intestinal hypersecretion.
    Lönnroth I; Holmgren J; Lange S
    Med Biol; 1977 Jun; 55(3):126-9. PubMed ID: 197323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of loperamide.
    Sandhu BK; Milla PJ; Harries JT
    Scand J Gastroenterol Suppl; 1983; 84():85-92. PubMed ID: 6314491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mediators formed in the small intestine in response to cholera toxin.
    Peterson JW; Cantu J; Duncan S; Chopra AK
    J Diarrhoeal Dis Res; 1993 Dec; 11(4):227-34. PubMed ID: 8188995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbachol potentiates cholera toxin-induced secretion in a colonic epithelial cell line (HT29-19A) and rat ileal mucosa in vitro.
    Mahmood B; Warhurst G; Higgs N; Turnberg LA
    J Health Popul Nutr; 2000 Jun; 18(1):49-53. PubMed ID: 11014771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1.
    Chambers TJ; Ali NN
    J Pathol; 1983 Mar; 139(3):383-97. PubMed ID: 6339702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a hormone-like factor which inhibits cholera secretion.
    Lönnroth I; Lange S
    FEBS Lett; 1984 Nov; 177(1):104-8. PubMed ID: 6500048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibitory effect of lanreotide (BIM 23014), a new somatostatin analog, on prostaglandin- and cholera toxin-stimulated intestinal fluid in the rat.
    Botella A; Vabre F; Fioramonti J; Thomas F; Bueno L
    Peptides; 1993; 14(2):297-301. PubMed ID: 8097869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of intestinal secretion in rats by colchicine and vinblastine.
    Notis WM; Orellana SA; Field M
    Gastroenterology; 1981 Oct; 81(4):766-72. PubMed ID: 6266907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.